Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04597814
What this trial is testing

The Relationship Between the Tumor Markers and Interstitial Lung Disease

Who this might be right for
the Relationship Between the Tumor Markers and Interstitial Lung Disease Patients
The First Affiliated Hospital of Guangzhou Medical University 13
Not applicableUnknownNCT04304898
What this trial is testing

An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology

Who this might be right for
Pulmonary Fibrosis
Erasmus Medical Center 700
Testing effectiveness (Phase 2)Study completedNCT06513338
What this trial is testing

Complement C5 mAb in the Treatment of Anti-GBM Disease

Who this might be right for
Autoimmune Diseases
Peking University First Hospital 16
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05285878
What this trial is testing

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Interstitial FibrosisKidney Transplant; ComplicationsKidney Transplant Rejection+4 more
The Methodist Hospital Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT03213678
What this trial is testing

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more
National Cancer Institute (NCI) 18
Not applicableActive Not RecruitingNCT07202260
What this trial is testing

Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung

Who this might be right for
Lung Cancer (NSCLC)Lung Cancer (SCLC)
The Christie NHS Foundation Trust 80
Testing effectiveness (Phase 2)UnknownNCT05747508
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon 85
Not applicableStudy completedNCT03588260
What this trial is testing

Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Istanbul Medipol University Hospital 60
Not applicableLooking for participantsNCT05681962
What this trial is testing

Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy

Who this might be right for
Acute Respiratory FailurePneumoniaLung Cancer+2 more
University Magna Graecia 10,000
Not applicableUnknownNCT03813810
What this trial is testing

Impact of Air Pollution on Chronic Respiratory Diseases

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAsthmaIdiopathic Pulmonary Fibrosis
Seoul National University Hospital 360
Not applicableUnknownNCT05482607
What this trial is testing

Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France 100
Testing effectiveness (Phase 2)WithdrawnNCT03720483
What this trial is testing

Inhaled NAC in Treatment of IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT03270020
What this trial is testing

Denosumab for the Treatment of Adult LCH

Who this might be right for
Langerhans Cell Histiocytosis
Hellenic Society for the Study of Bone Metabolism 10
Not applicableStudy completedNCT04488562
What this trial is testing

Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands

Who this might be right for
COVID-19Pulmonary Fibrosis
Erasmus Medical Center 133
Not applicableLooking for participantsNCT06245954
What this trial is testing

The Role of Standardized Training in the Diagnosis of Interstitial Lung Disease by Transbronchial Lung Cryobiopsy

Who this might be right for
Transbronchial Lung Cryobiopsy
China-Japan Friendship Hospital 20
Not applicableActive Not RecruitingNCT07531446
What this trial is testing

Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters

Who this might be right for
Dermatomyositis (DM)ILDMachine Learning+1 more
Ruijin Hospital 200
Not applicableUnknownNCT05890573
What this trial is testing

Efficacy of Bailing Capsule on Pulmonary Fibrosis After COVID-19

Who this might be right for
Pulmonary FibrosisCOVID-19 Pneumonia
Second Affiliated Hospital, Zhejiang University, School of Medicine 242
Not applicableLooking for participantsNCT06159660
What this trial is testing

Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy

Who this might be right for
Lung Neoplasm
University of Sydney 15
Not applicableStudy completedNCT06016959
What this trial is testing

Specialist Dietetic Intervention in Malnourished Patients with Fibrotic ILD: a Randomised Controlled Pilot Trial

Who this might be right for
Interstitial Lung Disease
Royal Brompton & Harefield NHS Foundation Trust 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06825169
What this trial is testing

A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects With Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)
Nuwacell Biotechnologies Co., Ltd. 30
Next Page